Who
Jake Simson
Director
Company insider
Files Form 4 as: Director, Septerna; Director, Janux Therapeutics; Director, Parabilis Medicines; Director, Bicara Therapeutics; Director, Tyra Biosciences; Director, DICE Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 10 Jun 2021
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | PBLS Parabilis Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,215 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | PBLS Parabilis Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,215 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | BCAX Bicara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,475 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | BCAX Bicara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,475 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 17 Jun 2025filed 20 Jun 2025 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,623 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,667 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 9 Jun 2025filed 10 Jun 2025 | BCAX Bicara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,746 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,200 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | BCAX Bicara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,746 at $0.00 | filing |
| 26 Jun 2024filed 28 Jun 2024 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,350 at $0.00 | filing |
| 26 Jun 2024filed 28 Jun 2024 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.